These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35066509)

  • 1. Esmolol to Treat the Hemodynamic Effects of Septic Shock: A Randomized Controlled Trial.
    Cocchi MN; Dargin J; Chase M; Patel PV; Grossestreuer A; Balaji L; Liu X; Moskowitz A; Berg K; Donnino MW
    Shock; 2022 Apr; 57(4):508-517. PubMed ID: 35066509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial.
    Morelli A; Ertmer C; Westphal M; Rehberg S; Kampmeier T; Ligges S; Orecchioni A; D'Egidio A; D'Ippoliti F; Raffone C; Venditti M; Guarracino F; Girardis M; Tritapepe L; Pietropaoli P; Mebazaa A; Singer M
    JAMA; 2013 Oct; 310(16):1683-91. PubMed ID: 24108526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic and anti-inflammatory effects of early esmolol use in hyperkinetic septic shock: a pilot study.
    Levy B; Fritz C; Piona C; Duarte K; Morelli A; Guerci P; Kimmoun A; Girerd N
    Crit Care; 2021 Jan; 25(1):21. PubMed ID: 33413583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Esmolol improves clinical outcome and tissue oxygen metabolism in patients with septic shock through controlling heart rate].
    Xinqiang L; Weiping H; Miaoyun W; Wenxin Z; Wenqiang J; Shenglong C; Juhao Z; Hongki Z
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Sep; 27(9):759-63. PubMed ID: 26955704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of esmolol in septic shock patients with tachycardia: a randomized clinical trial].
    Liu H; Ding XF; Zhang SG; Wang HX; Luo YG; Duan XG; Liu SH; Zhang RF; Zhang XJ; Qin CH; Han B; Wang Y; Sun TW
    Zhonghua Yi Xue Za Zhi; 2019 May; 99(17):1317-1322. PubMed ID: 31091579
    [No Abstract]   [Full Text] [Related]  

  • 6. Heart rate reduction with esmolol is associated with improved arterial elastance in patients with septic shock: a prospective observational study.
    Morelli A; Singer M; Ranieri VM; D'Egidio A; Mascia L; Orecchioni A; Piscioneri F; Guarracino F; Greco E; Peruzzi M; Biondi-Zoccai G; Frati G; Romano SM
    Intensive Care Med; 2016 Oct; 42(10):1528-1534. PubMed ID: 27101380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of esmolol on fluid responsiveness and hemodynamic parameters in patients with septic shock].
    Tao Y; Jingyi W; Xiaogan J; Weihua L; Xiaoju J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Nov; 27(11):885-9. PubMed ID: 27132454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of Esmolol in Treatment of Patients with Septic Shock.
    Du W; Wang XT; Long Y; Liu DW
    Chin Med J (Engl); 2016 Jul; 129(14):1658-65. PubMed ID: 27411452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of esmolol on hemodynamics and clinical outcomes in patients with septic shock].
    Wang S; Li M; Duan J; Yi L; Huang X; Chen D; Li G
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 May; 29(5):390-395. PubMed ID: 28524025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Esmolol infusion in patients with septic shock and tachycardia: a prospective, single-arm, feasibility study.
    Brown SM; Beesley SJ; Lanspa MJ; Grissom CK; Wilson EL; Parikh SM; Sarge T; Talmor D; Banner-Goodspeed V; Novack V; Thompson BT; Shahul S;
    Pilot Feasibility Stud; 2018; 4():132. PubMed ID: 30123523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The scientific rationale and study protocol for the DPP3, Angiotensin II, and Renin Kinetics in Sepsis (DARK-Sepsis) randomized controlled trial: serum biomarkers to predict response to angiotensin II versus standard-of-care vasopressor therapy in the treatment of septic shock.
    Teixeira JP; Perez Ingles D; Barton JB; Dean JT; Garcia P; Kunkel SJ; Sarangarm P; Weiss NK; Schaich CL; Busse LW; Nielsen ND
    Trials; 2024 Mar; 25(1):182. PubMed ID: 38475822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of low doses of esmolol on cardiac and vascular function in experimental septic shock.
    Wei C; Louis H; Schmitt M; Albuisson E; Orlowski S; Levy B; Kimmoun A
    Crit Care; 2016 Dec; 20(1):407. PubMed ID: 27998289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study.
    Briegel J; Forst H; Haller M; Schelling G; Kilger E; Kuprat G; Hemmer B; Hummel T; Lenhart A; Heyduck M; Stoll C; Peter K
    Crit Care Med; 1999 Apr; 27(4):723-32. PubMed ID: 10321661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systolic-dicrotic notch pressure difference can identify tachycardic patients with septic shock at risk of cardiovascular decompensation following pharmacological heart rate reduction.
    Morelli A; Romano SM; Sanfilippo F; Santonocito C; Frati G; Chiostri M; Agrò FE; Ertmer C; Rehberg SW; Vieillard-Baron A
    Br J Anaesth; 2020 Dec; 125(6):1018-1024. PubMed ID: 32690246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of efficacy and safety of esmolol in treating patients with septic shock: A protocol for systematic review and meta-analysis.
    Hou B; Cai K; Li Y; Hu C; Pu X
    Medicine (Baltimore); 2022 Apr; 101(13):e29124. PubMed ID: 35421065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of the β-blockers on cardiac protection and hemodynamics in patients with septic shock: a prospective study].
    Yang S; Liu Z; Yang W; Zhang G; Hou B; Liu J; Shi Q
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Oct; 26(10):714-7. PubMed ID: 25315942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of esmolol on systemic hemodynamics and heart rate variability measured using the Analgesia/Nociception Index in resuscitated piglets with Pseudomonas aeruginosa septic shock.
    Boselli E; Jacquet-Lagrèze M; Ayoub JY; Bouvet L; Dauwalder O; Mansour C; Margez T; Paquet C; Restagno D; Allaouchiche B; Bonnet-Garin JM; Junot S
    J Vet Emerg Crit Care (San Antonio); 2018 Sep; 28(5):447-456. PubMed ID: 30074662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β1-Adrenergic Inhibition Improves Cardiac and Vascular Function in Experimental Septic Shock.
    Kimmoun A; Louis H; Al Kattani N; Delemazure J; Dessales N; Wei C; Marie PY; Issa K; Levy B
    Crit Care Med; 2015 Sep; 43(9):e332-40. PubMed ID: 25962080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut and sublingual microvascular effect of esmolol during septic shock in a porcine model.
    Jacquet-Lagrèze M; Allaouchiche B; Restagno D; Paquet C; Ayoub JY; Etienne J; Vandenesch F; Dauwalder O; Bonnet JM; Junot S
    Crit Care; 2015 Jun; 19(1):241. PubMed ID: 26041462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microvascular effects of heart rate control with esmolol in patients with septic shock: a pilot study.
    Morelli A; Donati A; Ertmer C; Rehberg S; Kampmeier T; Orecchioni A; D'Egidio A; Cecchini V; Landoni G; Pietropaoli P; Westphal M; Venditti M; Mebazaa A; Singer M
    Crit Care Med; 2013 Sep; 41(9):2162-8. PubMed ID: 23873274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.